Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Kelly McCann"'
Autor:
Dylan R. Kirn, Joshua D. Grill, Paul Aisen, Karin Ernstrom, Seth Gale, Judith Heidebrink, Gregory Jicha, Gustavo Jimenez-Maggiora, Leigh Johnson, Elaine Peskind, Kelly McCann, Elizabeth Shaffer, David Sultzer, Shunran Wang, Reisa Sperling, Rema Raman
Publikováno v:
Alzheimer’s Research & Therapy, Vol 15, Iss 1, Pp 1-9 (2023)
Abstract Background Recruiting to multi-site trials is challenging, particularly when striving to ensure the randomized sample is demographically representative of the larger disease-suffering population. While previous studies have reported disparit
Externí odkaz:
https://doaj.org/article/993b35f17a694323b50156da6fb072c1
Autor:
Maitri Kalra, Elizabeth Henry, Kelly McCann, Meghan S Karuturi, Jean G Bustamante Alvarez, Amanda Parkes, Robert Wesolowski, Mei Wei, Sarah S Mougalian, Gregory Durm, Angel Qin, Caitlin Schonewolf, Meghna Trivedi, Avan J Armaghani, Frederick H Wilson, Wade T Iams, Anita A Turk, Praveen Vikas, Michael Cecchini, Sam Lubner, Priyadarshini Pathak, Kristen Spencer, Vadim S Koshkin, Matthew K Labriola, Catherine H Marshall, Katy E Beckermann, Marina N Sharifi, Anthony C Bejjani, Varsha Hotchandani, Samir Housri, Nadine Housri
Publikováno v:
JMIR Cancer, Vol 8, Iss 2, p e33859 (2022)
BackgroundExpert knowledge is often shared among multidisciplinary academic teams at tumor boards (TBs) across the country, but these conversations exist in silos and do not reach the wider oncology community. ObjectiveUsing an oncologist-only quest
Externí odkaz:
https://doaj.org/article/b5128dc2db1f4f718a05df5e4722645d
Autor:
Michael C. Heinrich, Ujwal Shinde, Christopher Corless, Jason K. Sicklick, Oliver Harismendy, Carol Beadling, Kelly McCann, Lillian R. Klug, Ajia Town, Isaac Forquer, Jason Kent, Amber E. Bannon
Purpose: Patients who inherit a pathogenic loss-of-function genetic variant involving one of the four succinate dehydrogenase (SDH) subunit genes have up to an 86% chance of developing one or more cancers by the age of 50. If tumors are identified an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f3a5a605d8ced1c183bff44000e3485
https://doi.org/10.1158/1078-0432.c.6526874
https://doi.org/10.1158/1078-0432.c.6526874
Autor:
Michael C. Heinrich, Ujwal Shinde, Christopher Corless, Jason K. Sicklick, Oliver Harismendy, Carol Beadling, Kelly McCann, Lillian R. Klug, Ajia Town, Isaac Forquer, Jason Kent, Amber E. Bannon
TIFF file for supplemental figure 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f1dc565c5e4ed85dd4751f41ed47cdf
https://doi.org/10.1158/1078-0432.22468244.v1
https://doi.org/10.1158/1078-0432.22468244.v1
Autor:
Michael C. Heinrich, Ujwal Shinde, Christopher Corless, Jason K. Sicklick, Oliver Harismendy, Carol Beadling, Kelly McCann, Lillian R. Klug, Ajia Town, Isaac Forquer, Jason Kent, Amber E. Bannon
TIFF file for supplemental figure 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5e8765299eaffb881c2372f926ecd15
https://doi.org/10.1158/1078-0432.22468247
https://doi.org/10.1158/1078-0432.22468247
Autor:
Michael C. Heinrich, Ujwal Shinde, Christopher Corless, Jason K. Sicklick, Oliver Harismendy, Carol Beadling, Kelly McCann, Lillian R. Klug, Ajia Town, Isaac Forquer, Jason Kent, Amber E. Bannon
Video for Biochemical, molecular, and clinical characterization of SDHA VUS from Biochemical, Molecular, and Clinical Characterization of Succinate Dehydrogenase Subunit A Variants of Unknown Significance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3840ab0a53c1dbb5ab2323a20d206831
https://doi.org/10.1158/1078-0432.22468238.v1
https://doi.org/10.1158/1078-0432.22468238.v1
Autor:
Michael C. Heinrich, Ujwal Shinde, Christopher Corless, Jason K. Sicklick, Oliver Harismendy, Carol Beadling, Kelly McCann, Lillian R. Klug, Ajia Town, Isaac Forquer, Jason Kent, Amber E. Bannon
Supplemental tables 1 and 2, supplemental figure legends, supplemental video legend
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ecb7c8218c87b738896f0ef33e7dc33
https://doi.org/10.1158/1078-0432.22468241.v1
https://doi.org/10.1158/1078-0432.22468241.v1
Autor:
Aditya Bardia, Sara Hurvitz, Michael F. Press, Lisa S. Wang, Nicholas P. McAndrew, David Chan, Vu Phan, Deborah Villa, Merry L. Tetef, Erin Chamberlain, Nihal Abdulla, Thomas Lomis, Laura M. Spring, Steven Applebaum, Shaker Dakhil, Brian DiCarlo, David D. Kim, Evangelia Kirimis, William E. Lawler, Aashini K. Master, Kelly McCann, Edwin Hayashi, Christine Kivork, James Chauv
Publikováno v:
Cancer Research. 83:GS2-03
Background: Although patients (pts) with hormone receptor-positive (HR+)/HER2-negative breast cancer (BC) frequently experience disease response to neoadjuvant therapy, fewer than 10% achieve a pathologic complete response (pCR) with standard chemoth
BACKGROUND Expert knowledge is often shared among multidisciplinary academic teams at tumor boards (TBs) across the country, but these conversations exist in silos and do not reach the wider oncology community. OBJECTIVE Using an oncologist-only ques
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2c5eac85f71debdaf0f6a20815552191
https://doi.org/10.2196/preprints.33859
https://doi.org/10.2196/preprints.33859
Autor:
Michael Coppedge, John Gerring, Adam Glynn, Carl Henrik Knutsen, Staffan I. Lindberg, Daniel Pemstein, Brigitte Seim, Svend-Erik Skaaning, Jan Teorell, David Altman, Michael Bernhard, Fernando Bizzarro, Joshua Krusell, Matthew Maguire, Kyle Marquardt, Kelly McCann, Valeriya Mechkova, Farhad Miri, Josefine Pernes, Jeffrey Staton, Natalia Stepanova, Eitan Tzelgov, Yi-ting Wang
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::089b6ec3485f36309edb3708a437540d
https://doi.org/10.1017/9781108347860
https://doi.org/10.1017/9781108347860